Showing results (371-380 of 10,059) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|May 10, 2011
Neuropeptide - adipose tissue communication and intestinal pathophysiologyIordanes Karagiannides, Kyriaki Bakirtzi, Charalabos PothoulakisCurrent Pharmaceutical Design|May 10, 2011
Sulforaphane enhances protection and repair of gastric mucosa against oxidative stress in vitro, and demonstrates anti-inflammatory effects on Helicobacter pylori-infected gastric mucosae in mice and human subjectsAkinori YanakaCurrent Pharmaceutical Design|April 21, 2011
Drug discovery of antimicrobial photosensitizers using animal modelsSulbha K Sharma, Tianhong Dai, Gitika B Kharkwal, et al.Current Pharmaceutical Design|April 21, 2011
The ubiquitin-proteasome system (UPS) and the mechanism of action of bortezomibBoris Cvek, Zdenek DvorakCurrent Pharmaceutical Design|April 29, 2011
NAP (davunetide) provides functional and structural neuroprotectionIllana GozesCurrent Pharmaceutical Design|April 29, 2011
VIP-induced neuroprotection of the developing brainSandrine Passemard, Paulina Sokolowska, Leslie Schwendimann, et al.Current Pharmaceutical Design|April 29, 2011
Immunomodulatory roles of VIP and PACAP in models of multiple sclerosisCatalina Abad, James A WaschekCurrent Pharmaceutical Design|April 29, 2011
Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drugS Bourgault, D Chatenet, O Wurtz, et al.Current Pharmaceutical Design|April 29, 2011
The potential interest of topiramate in addictionGabriel Thorens, Joel Billieux, Rita Manghi, et al.Current Pharmaceutical Design|April 29, 2011
GABAergic and glutamatergic modulation in binge eating: therapeutic approachDewi Guardia, Benjamin Rolland, Laurent Karila, et al.Pageof 1,006